GENEVA—Alcon (SIX/NYSE:ALC), a global eyecare company with a portfolio of both surgical and vision care products, has announced its financial results for the three- and six-month periods ending June 30, 2024. For the second quarter of 2024, sales were reported at $2.5 billion, an increase of 3 percent on a reported basis and 6 percent on a constant currency basis, as compared with the same quarter of the previous year. Sales for the first half of 2024 were $4.9 billion, an increase of 4 percent on a reported basis and 7 percent on a constant currency basis, compared with the first half of 2023, the announcement said. Read More